1. Li S*, Topatana W*, Juengpanich S*, Cao J, Hu J, Zhang B, Ma D, Cai X#, Chen M#. Development of Synthetic Lethality in Cancer: Molecular and Cellular. Signal Transduction and Targeted Therapy.(通讯作者，SCI，中科院Top, 一区，IF=13.07)
2. Topatana W*, Juengpanich S*, Li S*, Cao J, Hu J, Lee J, Suliyanto K, Ma D, Zhang B, Chen M#, Cai X#. Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation. J Hematol Oncol. 2020 Sep 3;13(1):118. (共同通讯作者，SCI，中科院Top, 一区，IF=11.09)
3. Chen M, Cai X. Synthetic Lethality Is a Novel and Potential Paradigm for Precision Medicine in Advanced Hepatocellular Carcinoma. Liver Cancer. 2020 Apr;9(2):225-226. (第一作者，SCI，中科院Top, 一区，IF=9.72)
4. Chen M, Zhang B, Topatana W, Cao J, Zhu H, Juengpanich S, Mao Q, Yu H, Cai X. Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning. NPJ Precis Oncol. 2020 Jun 8;4:14. (第一作者，SCI，二区，IF=7.07)
5. Chen M, Hu J, Cao J, Cai X. Comprehensive Consideration before the Decision-Making of the Systemic Treatment in Patients with Advanced Hepatocellular Carcinoma. Liver Cancer. 2020 Apr;9(2):221-222. (第一作者，SCI，中科院Top, 一区，IF=9.72)
6. Chen M, Lin J, Cao J, Zhu H, Zhang B, Wu A, Cai X. Development and validation of a nomogram for survival benefit of lymphadenectomy in resected gallbladder cancer. Hepatobiliary Surg Nutr. 2019 Oct;8(5):480-489.(第一作者，SCI，二区，IF=5.29)
7. Chen M, Hu J, Cai X. Ectopic Thyroid Gland Tissue in the Liver. Clin Gastroenterol Hepatol. 2019 Oct 5:S1542-3565(19)31093-6.(第一作者，SCI，中科院Top, 一区，IF=8.55)
8. Pan L*, Chen M*, Ji L, Zheng L, Yan P, Fang J, Zhang B, Cai X. The Safety and Efficacy of Laparoscopic Common Bile Duct Exploration Combined with Cholecystectomy for the Management of Cholecysto-choledocholithiasis: An Up-to-date Meta-analysis. Ann Surg. 2018 Aug;268(2):247-253. (共同第一作者，SCI，中科院Top, 一区，IF=10.13)
9. Chen M, Cao J, Bai Y, Tong C, Lin J, Jindal V, Barchi LC, Nadalin S, Yang SX, Pesce A, Panaro F, Ariche A, Kai K, Memeo R, Bekaii-Saab T, Cai X; Written on behalf of the AME Gallbladder Cancer Collaborative Group. Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder Lesions. Clin Transl Gastroenterol. 2019 Oct;10(10):e00098. (第一作者，SCI，二区，IF=3.97)
10. Cao J, Cai X, Chen M: Liver Injury in COVID-19: Caution and Management. Liver Cancer 2020;9:625-626. (通讯作者，SCI，中科院Top, 一区，IF=9. 72)
11. Cao J, Wang Y, Zhang B, Hu J, Topatana W, Li S, Juengpanich S, Lu Z, Cai X, Chen M. Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer. Front Oncol. 2021 Oct 28;11:758319. (通讯作者，SCI，二区，IF=6.4)
12. Hu J, Cao J, Topatana W, Juengpanich S, Li S, Zhang B, Shen J, Cai L, Cai X, Chen M. Targeting mutant p53 for cancer therapy: direct and indirect strategies. J Hematol Oncol. 2021 Sep 28;14(1):157. （通讯作者，SCI，中科院Top, 一区，IF=16.5)
13. Zhang B, Chen M, Cao J, Liang Y, Tu T, Hu J, Li T, Cai Y, Li S, Liu B, Xu J, Liang B, Ye X, Cai X. An integrated electrochemical POCT platform for ultrasensitive circRNA detection towards hepatocellular carcinoma diagnosis. Biosens Bioelectron. 2021 Nov 15;192:113500. （共一，SCI，IF=10.5)
14. Chen M, Cao J, Xiang Y, Ma X, Bai Y, Lai Q, Tong C, Ma Z, Topatana W, Hu J, Li S, Juengpanich S, Yu H, Cai X. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study. Surgery. 2021 Jun;169(6):1304-1311. （第一作者，SCI，IF=3+)
